Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of FibroGen Inc (NASDAQ: FGEN) was $1.12 for the day, down -3.45% from the previous closing price of $1.16. In other words, the price has decreased by -$3.45 from its previous closing price. On the day, 1.96 million shares were traded. FGEN stock price reached its highest trading level at $1.22 during the session, while it also had its lowest trading level at $1.075.
Ratios:
Our analysis of FGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 12 ’24 when Adib Deyaa bought 22,123 shares for $1.17 per share. The transaction valued at 25,884 led to the insider holds 82,123 shares of the business.
Wettig Thane bought 50,000 shares of FGEN for $95,470 on Mar 07 ’24. The CEO now owns 470,178 shares after completing the transaction at $1.91 per share. On Sep 01 ’23, another insider, Henderson Jeffrey William, who serves as the Director of the company, sold 2,000 shares for $1.03 each. As a result, the insider received 2,060 and left with 28,866 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 111412448 and an Enterprise Value of 143181440. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67. Its current Enterprise Value per Revenue stands at 0.855 whereas that against EBITDA is -0.594.
Stock Price History:
Over the past 52 weeks, FGEN has reached a high of $2.93, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is 2.00%, while the 200-Day Moving Average is calculated to be -4.87%.
Shares Statistics:
FGEN traded an average of 2.73M shares per day over the past three months and 2144320 shares per day over the past ten days. A total of 98.77M shares are outstanding, with a floating share count of 92.39M. Insiders hold about 7.12% of the company’s shares, while institutions hold 61.22% stake in the company. Shares short for FGEN as of 1721001600 were 5941928 with a Short Ratio of 2.18, compared to 1718323200 on 8088406. Therefore, it implies a Short% of Shares Outstanding of 5941928 and a Short% of Float of 7.04.
Earnings Estimates
The dynamic stock of FibroGen Inc (FGEN) is currently attracting attention from 3.0 analysts actively involved in rating its market status.On average, analysts expect EPS of -$0.32 for the current quarter, with a high estimate of -$0.24 and a low estimate of -$0.45, while EPS last year was -$0.9. The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.16 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$0.82 and -$1.82 for the fiscal current year, implying an average EPS of -$1.31. EPS for the following year is -$0.57, with 3.0 analysts recommending between $0.15 and -$1.05.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $32.17M. There is a high estimate of $35.53M for the next quarter, whereas the lowest estimate is $27M.
A total of 3 analysts have provided revenue estimates for FGEN’s current fiscal year. The highest revenue estimate was $158.15M, while the lowest revenue estimate was $136.09M, resulting in an average revenue estimate of $150.41M. In the same quarter a year ago, actual revenue was $147.75MBased on 3 analysts’ estimates, the company’s revenue will be $152.44M in the next fiscal year. The high estimate is $165.29M and the low estimate is $145M.
